| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
phenotype | 0.400 | None | 1.000 | 11 | 0 | 1995 | 2019 | ||||||||
|
interleukin 1 beta | 0.276 | 0.962 | 0.13 |
|
phenotype | 0.400 | None | 0.963 | 6 | 0 | 1995 | 2019 | ||||||||
|
transient receptor potential cation channel subfamily V member 1 | 0.446 | 0.885 | 1.0E-16 |
|
phenotype | 0.400 | None | 1.000 | 4 | 0 | 2002 | 2019 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
phenotype | 0.400 | None | 1.000 | 3 | 0 | 1995 | 2019 | ||||||||
|
nerve growth factor | 0.391 | 0.885 | 0.82 |
|
phenotype | 0.390 | None | 1.000 | 1 | 0 | 2010 | 2019 | ||||||||
|
transient receptor potential cation channel subfamily V member 4 | 0.457 | 0.808 | 2.2E-16 |
|
phenotype | 0.380 | None | 1.000 | 1 | 0 | 2007 | 2019 | ||||||||
|
transient receptor potential cation channel subfamily A member 1 | 0.546 | 0.846 | 7.2E-35 |
|
phenotype | 0.370 | None | 1.000 | 3 | 0 | 2007 | 2020 | ||||||||
|
glial fibrillary acidic protein | 0.421 | 0.885 | 1.5E-06 |
|
phenotype | 0.370 | None | 1.000 | 1 | 0 | 2016 | 2019 | ||||||||
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
phenotype | 0.360 | None | 0.875 | 2 | 0 | 1995 | 2018 | ||||||||
|
glutamate ionotropic receptor NMDA type subunit 2B | 0.510 | 0.692 | 1.00 |
|
phenotype | 0.360 | None | 1.000 | 1 | 0 | 2009 | 2019 | ||||||||
|
allograft inflammatory factor 1 | 0.521 | 0.808 | 1.9E-06 |
|
phenotype | 0.350 | None | 1.000 | 1 | 0 | 2016 | 2020 | ||||||||
|
high mobility group box 1 | 0.368 | 0.923 | 0.82 |
|
phenotype | 0.340 | None | 1.000 | 1 | 0 | 2016 | 2018 | ||||||||
|
C-C motif chemokine ligand 2 | 0.321 | 0.962 | 0.61 |
|
phenotype | 0.340 | None | 1.000 | 1 | 0 | 2007 | 2019 | ||||||||
|
glutamate ionotropic receptor NMDA type subunit 1 | 0.561 | 0.692 | 0.98 |
|
phenotype | 0.340 | None | 1.000 | 1 | 0 | 2016 | 2019 | ||||||||
|
tachykinin precursor 1 | 0.424 | 0.923 | 0.75 |
|
phenotype | 0.330 | None | 1.000 | 9 | 0 | 1996 | 2018 | ||||||||
|
mitogen-activated protein kinase 1 | 0.330 | 0.923 | 1.00 |
|
phenotype | 0.330 | None | 1.000 | 2 | 0 | 2003 | 2019 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
phenotype | 0.330 | None | 1.000 | 2 | 0 | 2007 | 2019 | ||||||||
|
opioid receptor mu 1 | 0.457 | 0.808 | 7.9E-11 |
|
phenotype | 0.330 | None | 1.000 | 1 | 0 | 2008 | 2019 | ||||||||
|
endothelin 1 | 0.380 | 0.846 | 0.46 |
|
phenotype | 0.330 | None | 1.000 | 1 | 0 | 2009 | 2020 | ||||||||
|
interleukin 1 receptor antagonist | 0.373 | 0.923 | 3.1E-02 |
|
phenotype | 0.320 | None | 1.000 | 4 | 0 | 1996 | 2019 | ||||||||
|
cannabinoid receptor 2 | 0.509 | 0.846 | 6.5E-06 |
|
phenotype | 0.320 | None | 1.000 | 2 | 0 | 2007 | 2019 | ||||||||
|
purinergic receptor P2X 3 | 0.565 | 0.769 | 1.0E-06 |
|
phenotype | 0.320 | None | 1.000 | 1 | 0 | 2009 | 2017 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
phenotype | 0.320 | None | 1.000 | 1 | 0 | 2014 | 2018 | ||||||||
|
adrenomedullin | 0.436 | 0.808 | 4.1E-02 |
|
phenotype | 0.320 | None | 1.000 | 1 | 0 | 2006 | 2019 | ||||||||
|
solute carrier family 12 member 5 | 0.570 | 0.654 | 1.00 |
|
phenotype | 0.320 | None | 1.000 | 1 | 0 | 2010 | 2019 |